BIOVIC B — Biovica International AB Cashflow Statement
0.000.00%
- SEK68.25m
- SEK30.86m
- SEK7.29m
Annual cashflow statement for Biovica International AB, fiscal year end - April 30th, SEK millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -30.3 | -39.4 | -60.1 | -110 | -127 |
Depreciation | |||||
Non-Cash Items | -0.349 | 0.146 | 0.052 | 0.007 | 0.367 |
Other Non-Cash Items | |||||
Changes in Working Capital | 1.66 | -1.31 | 1.48 | 7.6 | 2.48 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -24.8 | -34.4 | -52.1 | -94.6 | -115 |
Capital Expenditures | -7.04 | -3.56 | -3.4 | -2.78 | -0.146 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0 | — | — | — | -0.439 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -7.04 | -3.56 | -3.4 | -2.78 | -0.585 |
Financing Cash Flow Items | — | — | — | -25.2 | -16.7 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 55.7 | 143 | -0.136 | 122 | 79.5 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 23.9 | 105 | -55.6 | 24.5 | -34.9 |